Zepp Health (ZEPP) EV to EBITDA (2018 - 2026)

Zepp Health has reported EV to EBITDA for 9 years, with the latest figure at 1.5 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 170.75% year-over-year to 1.5 in Q2 2026; TTM through Jun 2026 was 0.53, a 288.7% decrease from a year earlier, with the FY2025 full-year figure at 11.73, down 926.37% from the prior year.
• EV to EBITDA was 1.5 for Q2 2026 at Zepp Health, up from 8.47 in the prior quarter.
• The five-year high for EV to EBITDA was 8.54 in Q2 2024, with the low at 775.93 in Q3 2025.
• Average EV to EBITDA over 5 years is 51.2, with a median of 2.04 recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: EV to EBITDA jumped 516.97% in 2023, then plunged 20325.01% in 2025.
• Over 5 years, EV to EBITDA stood at 4.03 in 2022, then tumbled by 1523.53% to 57.44 in 2023, then soared by 113.07% to 7.5 in 2024, then sank by 1280.37% to 88.58 in 2025, then jumped by 98.3% to 1.5 in 2026.
• The last three EV to EBITDA figures came in at 1.5 (Q2 2026), 8.47 (Q1 2026), and 88.58 (Q4 2025), per Business Quant data.